Cochlear changes following destruction of semicircular canal in healthy and previously toxin-exposed rats. An electrophysiological and morphological investigation.
One group of Sprague-Dawley rats (group A, n = 6) was treated by instilling Pseudomonas aeruginosa exotoxin A (PaExoA), and another (group B, n = 6) treated similarly with Haemophilus influenzae type b endotoxin (HiBEndo). In group A a 20 dB hearing loss was observed, predominantly in the high-frequency region, which was reversible within 1 month. In group B no significant hearing impairment was noted. Between 1 and 6 months later, the lateral and posterior semicircular canals (SCCs) were ablated unilaterally. Control rats (group C, n = 8) were subjected to ablation only. All rats were cochleotomized contralaterally prior to labyrinthine surgery. Frequency-specific evoked potential testing at 2-31.5 kHz tone bursts was performed before and directly after surgery, 6, 24 and 48 hours and 1, 4 and 16 weeks postoperatively. After surgery in 18 rats, thresholds rose immediately, predominantly at 2, 4 and 6 kHz, followed by varying degrees of recovery. Greatest immediate postoperative hearing loss was observed in group A; no rat recovered completely and two rats showed severe permanent threshold elevation. All group B rats recovered completely, except one showing moderate threshold impairment. No permanent hearing loss was observed in group C. This study shows that destruction of SCCs in rats does not necessarily cause permanent hearing loss, even if the fluid spaces are not sealed off. However, previous exposure of the middle ear to PaExoA (but not HiBEndo) renders the cochlea more vulnerable and can result in persistent hearing loss.
Stenqvist
M
M
Department of Oto-Rhino-Laryngology and Head & Neck Surgery, University Hospital (Akademiska Sjukhuset), Uppsala, Sweden. Monika.Stenqvist@ent.uas.se
Rask-Andersen
H
H
Anniko
M
M
D000818:Animals; D003051:Cochlea / Q000473:pathology; D004594:Electrophysiology; D004731:Endotoxins; D019741:Haemophilus influenzae type b; D006314:Hearing Loss, Conductive / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D006316:Hearing Loss, High-Frequency / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D006319:Hearing Loss, Sensorineural / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D008297:Male; D010033:Otitis Media / Q000150:complications*; D010865:Pilot Projects; D011183:Postoperative Complications / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D011550:Pseudomonas aeruginosa; D051381:Rats; D017207:Rats, Sprague-Dawley; D012307:Risk Factors; D012665:Semicircular Canals / Q000473:pathology / Q000601:surgery*
D004731:Endotoxins